The study of gene mutation on the patients with idiopathic basal ganglia calcification (IBGC) in Japan

The study of gene mutation on the patients with idiopathic basal ganglia calcification (IBGC) in Japan - The study of gene mutation on the patients with idiopathic basal ganglia calcification (IBGC) in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030100

Enrollment

500

Registered

2017-12-01

Start date

2017-11-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic basal ganglia calcification (IBGC)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Conspicuous calcification is observed in the basal ganglia and/or dentate nucleus on CT scanning image. Calcification is bilateral and symmetrical. Idiopathic (absence of biochemical abnormalities, and an infections, toxic, or traumatic cause).

Exclusion criteria

Exclusion criteria: To exclude diseases which show calcification, because of some causes such as hypoparathyroism, pseudo hypoparathyroism, pseudopseudo hypoparathyroism (Albright's osteodystrophy), Down syndrome, collagen diseases, angiitis, infections, intoxication, trauma, radiation therapy and so on.

Design outcomes

Primary

Measure	Time frame
To lay the foundation for future researches of IBGC.	—

Countries

Japan

Contacts

Public ContactIsao Hozumi

Gifu Pharmaceutical University Laboratory of Medical Therapeutics and Molecular Therapeutics

hozumi@gifu-pu.ac.jp058-230-8100

Outcome results